Table 5.
Hazard ratios for cancer and diabetes in the groups with different urinary findings in women
| Cause of deaths |
Control areas |
Polluted areas |
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Pro(-) and Glu(-) |
Pro(+) or/and Glu(+) |
Pro(-) and Glu(-) |
Pro(-) and Glu(+) |
Pro(+) and Glu(-) |
Pro(+) and Glu(+) |
||||||||||||
|
(N=1039) |
(N=133) |
(N=3184) |
(N=398) |
(N=136) |
(N=267) |
||||||||||||
| D | HR | D | HR | (95% CI) | D | HR | (95% CI) | D | HR | (95% CI) | D | HR | (95% CI) | D | HR | (95% CI) | |
| Malignant neoplasm |
97 |
1.00 |
17 |
1.57 |
(0.94, 2.64) |
339 |
1.03 |
(0.82, 1.31) |
51 |
1.34 |
(0.95, 1.90) |
21 |
1.97 |
(1.21, 3.19)** |
26 |
1.64 |
(1.05, 2.56)* |
| Esophagus |
0 |
1.00 |
0 |
- |
- |
2 |
- |
- |
2 |
- |
- |
0 |
- |
- |
0 |
- |
- |
| Stomach |
26 |
1.00 |
7 |
2.29 |
(0.99, 5.34) |
77 |
0.99 |
(0.62, 1.58) |
11 |
1.12 |
(0.55, 2.30) |
5 |
1.42 |
(0.49, 4.09) |
5 |
0.94 |
(0.35, 2.51) |
| Colon, rectum |
7 |
1.00 |
1 |
1.14 |
(0.14, 9.33) |
55 |
2.42 |
(1.10, 5.34)* |
5 |
1.77 |
(0.56, 5.59) |
0 |
- |
- |
6 |
4.27 |
(1.39, 13.1)* |
| Liver |
5 |
1.00 |
0 |
- |
- |
4 |
.54 |
(0.52, 4.54) |
2 |
0.70 |
(0.08, 6.27) |
1 |
2.59 |
(0.29, 23.3) |
0 |
- |
- |
| Gall bladder |
7 |
1.00 |
1 |
1.28 |
(0.16, 10.4) |
36 |
1.44 |
(0.63, 3.28) |
8 |
3.21 |
(1.16, 8.90)* |
1 |
1.40 |
(0.17, 11.4) |
1 |
1.09 |
(0.13, 9.09) |
| Pancreas |
12 |
1.00 |
2 |
1.60 |
(0.35, 7.24) |
25 |
0.60 |
(0.29, 1.24) |
4 |
0.89 |
(0.28, 2.82) |
3 |
2.39 |
(0.66, 8.62) |
2 |
1.03 |
(0.22, 4.85) |
| Lung |
17 |
1.00 |
2 |
1.03 |
(0.24, 4.50) |
35 |
0.50 |
(0.28, 0.92)* |
4 |
0.56 |
(0.19, 1.67) |
2 |
1.01 |
(0.23, 4.38) |
3 |
1.04 |
(0.29, 3.67) |
| Breast |
4 |
1.00 |
0 |
- |
- |
11 |
0.76 |
(0.24, 2.44) |
1 |
0.80 |
(0.09, 7.19) |
2 |
5.73 |
(1.04, 31.4)* |
0 |
|
|
| Uterus |
5 |
1.00 |
1 |
4.56 |
(0.41, 50.6) |
10 |
1.15 |
(0.24, 5.57) |
0 |
|
|
2 |
10.5 |
(1.46, 75.1)* |
3 |
10.8 |
(1.62, 71.7)* |
| Ovary |
5 |
1.00 |
0 |
- |
- |
7 |
1.17 |
(0.24, 5.67) |
2 |
2.73 |
(0.38, 19.6) |
0 |
- |
- |
0 |
|
|
| Bladder |
1 |
1.00 |
1 |
6.72 |
(0.40, 112) |
4 |
1.21 |
(0.13, 11.2) |
0 |
- |
- |
0 |
- |
- |
0 |
- |
- |
| Kidney and urinal tract |
1 |
1.00 |
0 |
- |
- |
3 |
0.82 |
(0.08, 8.06) |
1 |
2.61 |
(0.16, 42.1) |
2 |
19.4 |
(1.73, 217)* |
2 |
15.5 |
(1.25, 192)* |
| Lymph, blood forming organs |
4 |
1.00 |
1 |
2.46 |
(0.27, 22.0) |
20 |
1.38 |
(0.46, 4.08) |
3 |
2.10 |
(0.47, 9.46) |
2 |
5.11 |
(0.93, 28.1) |
2 |
4.56 |
(0.79, 26.1) |
| Endocrine, nutritional and metabolic diseases |
3 |
1.00 |
1 |
2.61 |
(0.27, 25.2) |
14 |
1.37 |
(0.39, 4.84) |
11 |
8.58 |
(2.38, 30.9)*** |
1 |
2.70 |
(0.28, 26.1) |
4 |
6.67 |
(1.44, 31.0)* |
| Diabetes | 2 | 1.00 | 1 | 4.11 | (0.37, 45.6) | 6 | 0.81 | (0.16, 4.09) | 11 | 12.7 | (2.80, 57.8)*** | 1 | 4.21 | (0.38, 46.8) | 4 | 10.0 | (1.73, 57.8)** |
Pro(+): urinary protein ≥ 10 mg/dL, Pro(-): urinary protein <10 mg/dL, Glu(+): urinary glucose ≥ +/-, Glu(-): urinary glucose negative.
N number of subjects, D number of deaths, HR Hazard ratio, CI confident interval.
*P < 0.05, **P < 0.01, ***P < 0.001 compared with Pro(-) and Glu(-) in controls.